Search Results 3531-3540 of 25421 for oral

  1. Allergy skin tests - Doctors & Departments - Mayo Clinic

    ... Oral lichen planus, Blue rubber bleb nevus syndrome, Burning mouth syndrome, Diffuse capillary malformation with overgrowth, Canker sores, Scarring alopecia ...

  2. Publications - Pedro Malavet, M.D. - Mayo Clinic

    Perioperative Resumption of Direct Oral Anticoagulants: Review of the Mayo Clinic Experience. South Med J. 2021 Jul; 114 (7):442-444. View PubMed; Scolapio JS ...

  3. Meet Our Residents - Orthodontics Residency (Minnesota) - Mayo Clinic College of Medicine & Science

    Connect with Mayo Clinic Oral Health on social media. Close. Academics ▸ Residencies and Fellowships ▸ Orthodontics Residency (Minnesota) ▸ Meet Our ...

  4. Publications - Michael M. Pham, M.D. - Mayo Clinic

    Rolak S, Pham MM, Lam-Himlin DM, Batheja MJ. New diagnosis of granulomatosis with polyangiitis presenting with oral ulcerations, ileitis, and hematochezia.

  5. Radial vs. State-Of-The-Art Femoral Access for Bleeding and Access Site Complication Reduction in Cardiac Catheterization (REBIRTH) - Mayo Clinic

    ... oral factor Xa or IIa inhibitors ≤ 24 h before procedure - Planned staged PCI within 30 days after index procedure. - Any planned surgeries within 30 days ...

  6. Mayo Clinic Q and A: Understanding burning mouth syndrome

    Psychological factors, such as anxiety, depression or stress, and some oral habits, such as tongue thrusting, biting the tip of your tongue and grinding your ...

  7. Strontium chloride sr 89 (intravenous route, injection route) - Side effects & dosage - Mayo Clinic

    Radiopharmaceuticals are radioactive agents that may be used to diagnose some diseases by studying the function of the body's organs or to treat certain ...

  8. Small bowel cancer - Doctors and departments - Mayo Clinic

    ... Oral biopsy, Cancer, Head and neck cancer, Facial fracture, Osteoradionecrosis, Chondrosarcoma, Nasal and paranasal tumors, Thyroid cancer, Soft tissue ...

  9. Evaluation of Extended Wear Infusion Set (EWIS) in Patients With Type 1 Diabetes - Mayo Clinic

    Subject has taken any oral, injectable, or IV glucocorticoids within 8 weeks from time of screening visit, or plans to take any oral, injectable, or IV ...

  10. A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus - Mayo Clinic

    * Oral corticosteroid (OCS; prednisone or equivalent) background therapy is permitted but not required. For participants taking OCS, the dose must be stable ...